| Predictor | 1 year | 2 years | ||||||
| Unadjusted OR (95% CI) | p Value | Adjusted OR (95% CI) | p Value | Unadjusted OR (95% CI) | p Value | Adjusted OR (95% CI) | p Value | |
| HAQ score | 1.84 (1.12 to 3.01) | 0.02 | 1.87 (1.11 to 3.15) | 0.02 | 1.47 (0.94 to 2.29) | 0.09 | 1.42 (0.89 to 2.26) | 0.14 |
HAQ, Health Assessment Questionnaire.
This table illustrates OR of stopping methotrexate for adverse events—OR displayed as unadjusted and adjusted for age, gender, symptom duration and steroid use at baseline.